New User? Sign Up | Sign In

Insider Trading - Regulus Therapeutics Inc. (RGLS)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
RGLS Insider Trading Transactions for Regulus Therapeutics Inc.
Goto page 0, 1, 2, 3, 4, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-01-02
Sale
2020-01-03
4:06 pm
Regulus Therapeutics Inc. RGLS Aker Christopher Ray
VP
2,239 $0.9667 $2,164 29,307
(Direct)
View
2020-01-02
Sale
2020-01-03
4:07 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
8,345 $0.9667 $8,067 235,083
(Direct)
View
2020-02-18
Sale
2020-02-19
6:08 pm
Regulus Therapeutics Inc. RGLS Aker Christopher Ray
VP
888 $0.8305 $737 28,419
(Direct)
View
2020-02-18
Sale
2020-02-19
6:09 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
4,324 $0.8304 $3,591 230,759
(Direct)
View
2020-05-15
Sale
2020-05-18
4:27 pm
Regulus Therapeutics Inc. RGLS Aker Christopher Ray
VP
909 $0.6268 $570 27,510
(Direct)
View
2020-05-15
Sale
2020-05-18
4:28 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
4,426 $0.6267 $2,774 226,333
(Direct)
View
2020-08-14
Sale
2020-08-17
8:21 pm
Regulus Therapeutics Inc. RGLS Aker Christopher Ray
VP
872 $0.605 $528 26,638
(Direct)
View
2020-08-14
Sale
2020-08-17
8:22 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
4,245 $0.6049 $2,568 222,088
(Direct)
View
2020-11-16
Sale
2020-11-18
4:09 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
6,094 $0.5211 $3,176 215,994
(Direct)
View
2020-11-16
Sale
2020-11-18
4:10 pm
Regulus Therapeutics Inc. RGLS Aker Christopher Ray
VP
876 $0.5211 $456 25,762
(Direct)
View
2020-12-04
Purchase
2020-12-07
5:06 pm
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Direct)
View
2020-12-04
Purchase
2020-12-07
5:08 pm
Regulus Therapeutics Inc. RGLS BASKETT FOREST
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:09 pm
Regulus Therapeutics Inc. RGLS Behbahani Ali
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:10 pm
Regulus Therapeutics Inc. RGLS Chang Carmen
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:10 pm
Regulus Therapeutics Inc. RGLS Florence Anthony A. Jr.
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:11 pm
Regulus Therapeutics Inc. RGLS Makhzoumi Mohamad
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:12 pm
Regulus Therapeutics Inc. RGLS MAKOWER JOSHUA
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:12 pm
Regulus Therapeutics Inc. RGLS SANDELL SCOTT D
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:13 pm
Regulus Therapeutics Inc. RGLS Sonsini Peter W.
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:14 pm
Regulus Therapeutics Inc. RGLS Walker Paul Edward
10% Owner
4,398,602 $0.622 $2,735,930 6,451,056
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-12-24
Purchase
2019-12-26
5:02 pm
2019-12-24
2024-12-24
Regulus Therapeutics Inc. RGLS Sonsini Peter W.
10% Owner
9,009,000 $0.125 900,900
(Indirect)
View
2019-12-24
Purchase
2019-12-26
5:02 pm
2019-12-24
N/A
Regulus Therapeutics Inc. RGLS Sonsini Peter W.
10% Owner
900,900 $6.66 900,900
(Indirect)
View
2019-12-24
Purchase
2019-12-26
5:03 pm
2019-12-24
2024-12-24
Regulus Therapeutics Inc. RGLS Walker Paul Edward
10% Owner
9,009,000 $0.125 900,900
(Indirect)
View
2019-12-24
Purchase
2019-12-26
5:03 pm
2019-12-24
N/A
Regulus Therapeutics Inc. RGLS Walker Paul Edward
10% Owner
900,900 $6.66 900,900
(Indirect)
View
2019-12-24
Purchase
2020-01-03
9:53 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS DENNER ALEXANDER J
Sarissa Capital Management LP
Sarissa Capital Offshore Master Fund LP
Sarissa Capital Catapult Fund LLC
Sarissa Capital Hawkeye Fund LP
10% Owner
423,162 $0.666 6,083,471
(Indirect)
View
2019-12-24
Purchase
2020-01-03
9:53 pm
2019-12-24
2024-12-24
Regulus Therapeutics Inc. RGLS DENNER ALEXANDER J
Sarissa Capital Management LP
Sarissa Capital Offshore Master Fund LP
Sarissa Capital Catapult Fund LLC
Sarissa Capital Hawkeye Fund LP
10% Owner
4,231,620 $6.66 6,083,471
(Indirect)
View
2020-01-22
Option Award
2020-01-24
4:11 pm
N/A
2030-01-21
Regulus Therapeutics Inc. RGLS Aker Christopher Ray
VP
210,000 $1.31 210,000
(Direct)
View
2020-01-22
Option Award
2020-01-24
4:12 pm
N/A
2030-01-21
Regulus Therapeutics Inc. RGLS CALSADA CRISPINA
CFO
150,000 $1.31 150,000
(Direct)
View
2020-01-22
Option Award
2020-01-24
4:13 pm
N/A
2030-01-21
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
900,000 $1.31 900,000
(Direct)
View
2020-02-03
Conversion
2020-02-04
4:59 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director
846,320 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-04
4:59 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director
84,632 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-04
5:05 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS RASTETTER WILLIAM H
Director
225,940 $0 0
(Indirect)
View
2020-02-03
Conversion
2020-02-04
5:05 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS RASTETTER WILLIAM H
Director
22,594 $0 0
(Indirect)
View
2020-04-01
Other
2020-05-08
8:03 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS Sarissa Capital Offshore Master Fund LP
10% Owner
5,311 $0 2,627,037
(Direct)
View
2020-04-01
Other
2020-05-08
8:03 pm
2020-04-01
2024-05-07
Regulus Therapeutics Inc. RGLS Sarissa Capital Offshore Master Fund LP
10% Owner
23,243 $1.08 2,627,037
(Direct)
View
2020-04-01
Other
2020-05-08
8:03 pm
2020-04-01
2024-12-24
Regulus Therapeutics Inc. RGLS Sarissa Capital Offshore Master Fund LP
10% Owner
53,113 $0.666 2,627,037
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:37 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS BALTIMORE DAVID
Director
23,250 $0.88 23,250
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:38 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS Collier Kathryn J
Director
23,250 $0.88 23,250
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:39 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS Nunn Jason Raleigh
Director
23,250 $0.88 23,250
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:40 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director
23,250 $0.88 23,250
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:42 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS RASTETTER WILLIAM H
Director
23,250 $0.88 23,250
(Indirect)
View
2020-06-17
Option Award
2020-06-19
4:43 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS Rosen Hugh
Director
23,250 $0.88 23,250
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:44 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS Simeonidis Simos
Director
23,250 $0.88 23,250
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:45 pm
N/A
2030-06-16
Regulus Therapeutics Inc. RGLS Witz Pascale
Director
23,250 $0.88 23,250
(Direct)
View
2020-08-03
Option Award
2020-08-05
09:12 am
N/A
2030-08-02
Regulus Therapeutics Inc. RGLS Drygin Denis
Chief Scientific Officer
300,000 $0.6879 300,000
(Direct)
View
2020-12-04
Option Award
2020-12-07
4:21 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director
793,528 $0.6301 595,146
(Direct)
View
2020-12-04
Option Award
2020-12-07
4:21 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director
595,146 $0.125 595,146
(Direct)
View
2020-12-04
Option Award
2020-12-07
4:22 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
39,680 $0.6301 29,760
(Indirect)
View
2020-12-04
Option Award
2020-12-07
4:22 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Hagan Joseph P
CEO
29,760 $0.125 29,760
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:06 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
5,239,254 $0.125 6,451,056
(Direct)
View
2020-12-04
Purchase
2020-12-07
5:06 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
258,707 $6.22 6,451,056
(Direct)
View
2020-12-04
Purchase
2020-12-07
5:08 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS BASKETT FOREST
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:08 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS BASKETT FOREST
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:09 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Behbahani Ali
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:09 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS Behbahani Ali
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:10 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Chang Carmen
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:10 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS Chang Carmen
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:10 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Florence Anthony A. Jr.
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:10 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS Florence Anthony A. Jr.
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:11 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Makhzoumi Mohamad
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:11 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS Makhzoumi Mohamad
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:12 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS MAKOWER JOSHUA
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:12 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS MAKOWER JOSHUA
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:12 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS SANDELL SCOTT D
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:12 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS SANDELL SCOTT D
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:13 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Sonsini Peter W.
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:13 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS Sonsini Peter W.
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:14 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Walker Paul Edward
10% Owner
5,239,254 $0.125 6,451,056
(Indirect)
View
2020-12-04
Purchase
2020-12-07
5:14 pm
2020-12-04
N/A
Regulus Therapeutics Inc. RGLS Walker Paul Edward
10% Owner
258,707 $6.22 6,451,056
(Indirect)
View
Goto page 0, 1, 2, 3, 4, Next